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Neuronal differentiation and maturation
Schizophrenia
Bipolar disorderMicroRNAs (miRNAs) are single-stranded, non-coding RNA molecules that play important roles in the develop-
ment and functions of the brain. Extensive studies have revealed critical roles for miRNAs in brain development
and function. Dysregulation or altered expression ofmiRNAs is associatedwith abnormal brain development and
pathogenesis of neurodevelopmental diseases. This review serves to highlight the versatile roles of these small
RNA molecules in normal brain development and their association with neurodevelopmental disorders, in
particular, two closely related neuropsychiatric disorders of neurodevelopmental origin, schizophrenia and
bipolar disorder.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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MicroRNAs (miRNAs) are RNA molecules that belong to a family of
small non-coding RNAs with 20 to 25 nucleotides (Ambros, 2004;
Bartel, 2004). miRNAs post-transcriptionally regulate gene expression
by binding to the 3′ untranslated region (3′UTR) of their targetmessen-
ger RNAs (mRNAs) through base-pairing, which in turn triggers mRNA
degradation or translational inhibition. In mammalian cells, most
miRNA genes are transcribed by RNA polymerase II (Pol II) to primary
miRNAs (pri-miRNAs) that contain hundreds to thousands of nucleotideses, Beckman Research Institute
.
. This is an open access article underand extended hairpin structures (Bartel, 2004). Pri-miRNAs are fur-
ther processed in the nucleus by Drosha and DiGeorge syndrome
critical region gene 8 (DGCR8) to produce precursor miRNAs
(pre-miRNAs) with stem-loop structure. Pre-miRNAs are exported
into the cytoplasm by exportin-5/RanGTP and cleaved by Dicer to
form mature miRNAs. These mature miRNAs are then loaded into
the RNA-induced silencing complex (RISC), a ribonucleoprotein
complex that is composed of the human immunodeﬁciency virus
transactivating response RNA-binding protein (TRBP), Argonaute
2 (Ago2), and Dicer, to bind to the target mRNA to modulate gene
expression (Bartel, 2004; Kim, 2005).
miRNAs have been shown to regulate a variety of biological process-
es, including development, cell proliferation and fate speciﬁcation,
growth control, and apoptosis (Gao, 2010; Lang and Shi, 2012; Li and
Jin, 2010; Shi et al., 2010; Stefani and Slack, 2008). Extensive studies
have implicated miRNAs in the regulation of brain development andthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 1
miRNAs involved in neurodevelopment and associated with schizophrenia (Scz) or
bipolar disorder (BP).
CaMKIIγ Regulate pain behavior Pan, et al., (2014)
CaMKIIγ Associated with Scz 
through regulating NMDA 
receptor signaling
Kocerha, et al., (2009)
Associated with Scz and BP 
as revealed by elevated 
expression in these patients
Beveridge, et al., (2010), 
Smalheiser, et al., (2014)
miR-132 p250GAP Promote dendritic 
development
Impey, et al., (2010), Pathania, 
et al., (2012), Wayman, et al., 
(2008)
MeCP2 Regulate dendritic 
morphology
Klein, et al., (2007)
Mediate the integration of 
newborn neurons
Luikart, et al., (2011)
Regulates synaptic plasticity 
& recognition memory 
Hansen, et al., (2013), Hansen,
et al., (2010), Lambert, et al., 
(2010), Scott, et al., (2012)
RASA1 Promote axon extension Hancock, et al., (2014) 
RFX4 Potentiate NMDA receptor 
depolarization
Cheng, et al., (2007)
DNMT3A, GATA2, 
DPYSL3
Associated with Scz as 
revealed by reduced 
expression in the patients
Miller, et al., (2012)
miR-17 
family
p38 Inhibit neurogenic to 
gliogenic transition
Naka-Kaneda, et al., (2014)
BMPR2 Promote neural precursor 
cell proliferation
Mao, et al., (2014)
TRP53INP1 Enhance NSC self-renewal Garg, et al., (2013)
PTEN and TBR2 Control spinal neural 
progenitor patterning
Bian, et al., (2013)
OLIG2 Regulate spinal neural 
progenitor patterning
Chen, et al., (2011)
NPAS3 Associated with Scz as 
revealed by elevated 
expression in the patients
Santarelli, et al., (2011), 
Wong, et al., (2013)
Associated with Scz as 
revealed by higher serum 
level in sporadic patients
Shi, et al., (2012)
miR-200
family
SPITZ Control neuroepithelial 
expansion and neuroblast 
transition
Morante, et al., (2013)
ZEB Repress neural induction 
from embryonic stem cells
Du, et al., (2013)
SOX2, E2F3 Promote neural progenitor 
cell-cycle exit & neuronal 
differentiation 





Choi, et al., (2008)
miR-195 MBD1 Enhance neural stem cell 
proliferation and repress 
differentiation
Liu, et al., (2013)
Associated with Scz as 
revealed by decreased 
expression in the patients
Perkins, et al., (2007)
BDNF Regulates BDNF-related 
GABAergic gene transcripts 
in Scz subjects
Mellios, et al., (2009)
Associated with Scz as 
revealed by higher serum 
level in sporadic patients
Shi, et al., (2012)
miRNA Targets Function of miRNA Reference
The function of miRNAs in neurodevelopment is listed in gray andwhite boxes, whereas the
association with Scz and BP is indicated in orange and white boxes. SIRT1: sirtuin 1; ID2:
inhibitor of DNA binding 2; HDAC4: histone deacetylase 4; HER6: hairy-related 6; ZIC5: Zic
familymember 5; ELAVL3: ELAV (embryonic lethal, abnormal vision)-likeprotein 3;MCPIP1:
monocyte chemotactic protein-induced protein 1; STMN1: stathmin 1; NEUROD1: neuro-
genic differentiation 1; JAG1: jagged 1; CoREST: corepressor of REST;MAD1L1:MAD1mitotic
arrest deﬁcient-like 1; DPYD: dihydropyrimidine dehydrogenase; BDNF: brain-derived
neurotrophic factor; PDGFRα: platelet-derived growth factor receptor α; SOX6: SRY box 6;
FOXJ3: forkhead box protein J3; ZFP238: zinc ﬁnger protein 238; HES5: hairy and enhancer
of split-5; SCOP: suprachiasmatic nucleus circadian oscillatory protein; RASA1: RAS p21 pro-
tein activator 1; RFX4: regulatory factor X, 4; DNMT3A: DNA-methyltransferase 3A; GATA2:
GATA binding protein 2; DPYSL3: dihydropyrimidinase-like 3; p38: p38 mitogen-activated
protein kinase; BMPR2: bone morphogenetic protein receptor type II; TRP53INP1: transfor-
mation related protein 53 inducible nuclear protein 1; PTEN: phosphatase and tensin
homolog; TBR2: T-boxbrainprotein 2;OLIG2: oligodendrocyte transcription factor 2;NPAS3:
neuronal PAS domain protein 3; ZEB: zinc-ﬁnger E-box-binding homeobox; Sox2: SRYbox2;
E2F3: E2F transcription factor 3; ZFHX1: zinc ﬁnger homeobox 1; LFNG: lunatic fringe;
MBD1: methyl-CpG-binding domain protein 1.
miRNA Targets Function of miRNA Reference
miR-9 TLX Promote neuronal 
differentiation
Zhao, et al., (2009), Zhao, et 
al., (2013)
FOXG1 Promote neuronal 
differentiation
Shibata, et al., (2008)
HER5, HER9, 




Leucht, et al., (2008)
REST Promote neuronal 
differentiation
Laneve, et al., (2010), Packer, 
et al., (2008)
SENSELESS Promote neuronal 
differentiation
Li, et al., (2006)
SIRT1 Promote neuronal 
differentiation
Saunders, et al., (2010)
ID2 Promote neuronal  
differentiation
Annibali, et al., (2012)
HDAC4 Promote neuronal  
differentiation




differentiation & control 
neuronal production
Coolen, et al., (2012)
HES1 Promote neuronal 
differentiation & control 
HES1 oscillation
Bonev, et al., (2012), 
Goodfellow, et al., (2014), Tan, 
et al., (2012)
MCPIP1 Promote NPC proliferation 
& neuronal differentiation
Yang, et al., (2013)
STMN1 Promote NSC proliferation Delaloy, et al., (2010)
HAIRY1 Promote NSC proliferation Bonev, et al., (2011)
FOXP1 Control motor neuron 
development
Otaegi, et al., (2011)
ONECUT1 Specify motor neuron fate Luxenhofer, et al., (2014)
FOXP2 Promote neurite outgrowth 
& neuronal migration
Clovis, et al., (2012)
MAP1B Control axon extension 
& branching
Dajas-Bailador, et al., (2012)
DRD2 Associated with Scz 
through DRD2
Shi, et al., (2014)
miR-124 SCP1 Promote neuronal 
differentiation
Visvanathan, et al., (2007)
PTBP1 Promote neuronal 
differentiation
Makeyev, et al., (2007)
SOX9 Promote neuronal  differentiation Cheng, et al., (2009)
BAF53a Promote neuronal 
differentiation
Yoo, et al., (2009)
CREB1 Inhibit synaptic activity Rajasethupathy, et al., (2009)
LAMC1, ITGB1 Inhibit progenitor genes Cao, et al., (2007)
Ephrin-B1 Promote neuronal 
differentiation
Arvanitis, et al., (2010)
NEUROD1 Promote NSC proliferation Liu, et al., (2011)
RHOG Stimulate neuronal process 
complexity
JAG1 Promote neuronal fate 
determination
Akerblom, et al., (2012)
ROCK1 Promote neurite outgrowth 
& elongation
Gu, et al., (2014)
CoREST Promote radial migration 
of projection neurons
Volvert, et al., (2014)
EZH2 Promote neuronal 
differentiation & inhibit 
astrocyte differentiation
Neo, et al., (2014)
EGR1 Regulate spatial learning 
& social interactions 
Yang, et al., (2012)
EGR1 Regulate synaptic 
transmission & cognition
Wang, et al., (2013)
RGS4 Associated with Scz 
through RGS4
Gong, et al., (2013)
miR-137 LSD1 Promote neuronal 
differentiation
Sun, et al., (2011)
EZH2 Promote NSC proliferation Szulwach, et al., (2010)
MIB1 Inhibit dendritic 
differentiation
Smrt, et al., (2010)
Associated with Scz 
via the rs1625579 SNP 




Associated with Scz 
through these targets
Guan, et al., (2014), Kim, et 
al., (2012), Kwon, et al., (2013)
MAD1L1, DPYD, 
BDNF
Associated with Scz 
through these targets 
Hill, et al., (2014)
CACNA1C Associated with BP 
through CACNA1C 
Ferreira, et al., (2008), Sklar, et 
al., (2008)




Dugas, et al., (2010)
SOX6, HES5 Promote oligodendrocyte 
differentiation
Zhao, et al., (2010)
PARD3, PRKCI Promote neural precursor 
differentiation
Hudish, et al., (2013)
SCOP Attenuate NMDA-induced 
neuronal depolarization
Cheng, et al., (2007)
47E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53neurogenesis (Kosik, 2006; Kosik and Krichevsky, 2005; Lang and Shi,
2012; Li and Jin, 2010; Shi et al., 2008, 2010). Precise regulation of
miRNA expression is required for normal brain development, whereas
dysregulation of miRNA expression and function has been implicated
in the pathogenesis of a variety of neurological diseases, including
neurodevelopmental disorders and neurodegenerative diseases (Bian
48 E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53and Sun, 2011; Qurashi and Jin, 2010). This review will discuss recent
progress on understanding the roles of miRNAs in normal brain devel-
opment and the association of thesemiRNAs with neurodevelopmental
diseases, speciﬁcally schizophrenia and bipolar disorder, two closely
related disorders (Table 1).
miRNAs in neurodevelopment
Studies using animal models with deﬁciency in miRNA biogenesis
have revealed essential roles for miRNAs in brain development and
function. For example, Ago2-deﬁcient mice exhibited defects in neural
tube closure and mis-patterning of the forebrain (Liu et al., 2004). Loss
of Dicer in zebraﬁsh skewed brain development and the abnormal
brain phenotype could be rescued by introducing a miRNA, miR-430
(Giraldez et al., 2005). Conditional knockout of Dicer in mouse neural
stem cells led to smaller cortex (De Pietri Tonelli et al., 2008), presum-
ably because deletion of Dicer interfered with neural stem cell expan-
sion and differentiation (Andersson et al., 2010; Kawase-Koga et al.,
2010). Loss of Dicer expression in neurons caused abnormal neuronal
maturation, including reduced dendritic arborization and defective axo-
nal path ﬁnding (Davis et al., 2008). Deletion of Dicer in dopaminergic
neurons resulted in progressive loss of midbrain dopaminergic neurons
and Parkinson-like symptoms in mice (Cuellar et al., 2008; Kim et al.,
2007). Together, these studies demonstrate important roles for miRNAs
in neurodevelopment.
Several brain-speciﬁc or brain-enriched miRNAs have been identi-
ﬁed and characterized. The brain-speciﬁcmiRNAmiR-9 has been exten-
sively studied in neurogenesis. We have shown that there is a feedback
regulatory loop between miR-9 and the nuclear receptor TLX during
neural stemcell differentiation (Zhao et al., 2009). TLXplays anessential
role in maintaining neural stem cells in the proliferative and self-
renewable state (Liu et al., 2008; Qu et al., 2010; Shi et al., 2004;
Zhang et al., 2008). miR-9 inhibits the expression of TLX by base-
pairing to the 3′ UTR of TLX mRNA (Zhao et al., 2009), which in turn
reduces neural stem cell proliferation and promotes neural differentia-
tion. On the other hand, TLX represses the expression of miR-9 pri-
miRNAs by binding to their genomic loci (Zhao et al., 2009). An inverse
correlation was also observed between TLX and miR-9 expression in
neural stem cells and transit amplifying progenitors (Obernier et al.,
2011). The miR-9-TLX regulatory loop thus provides a precise control
over neural stem cell fate determination. Recently we showed that the
cascade of TLX and miR-9 acts downstream of let-7 family microRNAs
let-7b and let-7d, to regulate neurogenesis (Zhao et al., 2009, 2010a,
2013). A regulatory loop between miR-9 and REST (RE1-silencing
transcription factor) was also observed during neural differentiation
(Laneve et al., 2010; Packer et al., 2008). Recently, a negative feedback
circuit between miR-9 and hairy and enhancer of split 1 (Hes1) was
described, in which the input of miR-9 into the Hes1 oscillator controls
the timing of neural progenitor cell differentiation and cell fate determi-
nation (Goodfellow et al., 2014).
Congruent with its role in promoting differentiation of neural stem
cells (Zhao et al., 2009), miR-9 triggers neural differentiation from
embryonic stem cells as well (Saunders et al., 2010). The pro-
differentiation role of miR-9 is also evident in the observation that
miR-9 promotes Cajal–Retzius neuronal differentiation by targeting
forkhead box protein G1 (FoxG1) expression (Shibata et al., 2008).
miR-9 also promotes the differentiation and axonal projection of spinal
motoneurons by targeting forkhead box protein P1 (FoxP1) (Otaegi
et al., 2011) and speciﬁes motor neuron fate by regulating onecut
homeobox 1 expression (Luxenhofer et al., 2014). Moreover, miR-9 in-
hibits the expression of forkhead box protein P2 (FoxP2) to promote
the migration and maturation of cortical neurons (Clovis et al., 2012).
This miRNA could also regulate neuronal maturation by modulating
the expression of microtubule-associated protein 1b (Map1b) (Dajas-
Bailador et al., 2012). The observation that miR-9/9* together with
miR-124 was able to convert human ﬁbroblast cells into functionalneurons reinforces the essential role of miR-9 in neuronal differentia-
tion (Yoo et al., 2011).
In developing zebraﬁsh, miR-9 induces neurogenesis by targeting
the expression of hairy-related 5 (her5), hairy-related 9 (her9),
canopy1 (cnpy1), ﬁbroblast growth factor 8 (fgf8), and ﬁbroblast
growth factor receptor 1 (fgfr1) (Leucht et al., 2008). In Xenopus brains,
miR-9 inhibits neural progenitor cell proliferation and apoptosis by
suppressing the expression of Hairy 1, a member of the Hes (hairy and
enhancer of split) family genes (Bonev et al., 2011). In miR-9-2/3
knockout mice, in which two of the miR-9 genomic loci (miR-9-2 and
miR-9-3) were mutated, miR-9 was shown to regulate both neural pro-
genitor proliferation and differentiation in a cellular context-speciﬁc
manner (Shibata et al., 2011). In addition to its major role in inhibiting
neural stem cell proliferation and promoting neural differentiation,
miR-9 also participates in neural progenitor cell expansion at an early
stage (Delaloy et al., 2010).
miR-124 is a miRNA that is speciﬁcally expressed in the central ner-
vous system (Deo et al., 2006; Lagos-Quintana et al., 2002) and mostly
expressed in post-mitotic neurons (Akerblom et al., 2012; Maiorano and
Mallamaci, 2009). The expression of miR-124 increases during brain
development (Krichevsky et al., 2003, 2006; Sempere et al., 2004;
Smirnova et al., 2005). miR-124 promotes neuronal differentiation by
targeting genes such as small CTD phosphatases 1 (SCP1) (Visvanathan
et al., 2007), laminin gamma 1 (LAMC1) and integrin beta 1 (ITGB1)
(Cao et al., 2007), BAF complex 53 kDa subunit (BAF53a) (Yoo et al.,
2009), SRY-box containing gene 9 (Sox9) (Cheng et al., 2009),
polypyrimidine tract binding protein 1 (PTBP1) (Makeyev et al., 2007),
and ephrin-B1 (Arvanitis et al., 2010). In addition to its role in neuronal
differentiation, miR-124 regulates neuronal maturation by targeting
the expression of cAMP response element-binding protein (CREB)
(Rajasethupathy et al., 2009), LIM/homeobox protein 2 (Lhx2) (Sanuki
et al., 2011), Rho-associated coiled-coil-containing protein kinase 1
(ROCK1) (Gu et al., 2014), and the small GTPase Ras homolog growth-
related (RhoG) (Franke et al., 2012). Recently, miR-124 was shown to
regulate synaptic transmission and cognition by inhibiting the expression
of early growth response gene 1 (Egr1) (Wang et al., 2013; Yang et al.,
2012).
Ectopic expression of miR-124 in HeLa cells was shown to suppress
non-neuronal genes but stimulate neuronal genes, suggesting that
miR-124 has a pro-neuronal role (Lim et al., 2005). The observation
that viral transduction of miR-124 into human ﬁbroblast cells along
with miR-9/9* or myelin transcription factor 1-like (MYT1L) and POU
class 3 homeobox 2 (POU3F2 or BRN2) converted these cells into
functional neurons further supports the essential role of miR-124 in
neuronal differentiation (Ambasudhan et al., 2011; Yoo et al., 2011).
These studies together highlight the importance ofmiR-124 in neuronal
differentiation.
The brain-enriched miRNA miR-137 also plays a pro-differentiation
role in neural stem cells from the ventricular zone of embryonic
mouse brains (Sun et al., 2011) and the subventricular zone of adult
mouse brains (Silber et al., 2008). Increased expression of miR-137 led
to reduced neural stem cell proliferation and increased neural differen-
tiation. A regulatory loop of TLX-miR-137-lysine-speciﬁc histone
demethylase 1(LSD1) ensures the coordinated expression of TLX/LSD1
and miR-137 during the transition of neural stem cell proliferation
and differentiation, and provides a mechanism to control the dynamics
between cell proliferation and differentiation (Sun et al., 2011).
In another study,miR-137was shown to regulate adult hippocampal
neurogenesis by targeting the enhancer of zeste homolog 2 (Ezh2)
(Szulwach et al., 2010), a histone methyltransferase that is important
in maintaining the bivalent chromatin state of stem cells (Boyer et al.,
2006). In addition, miR-137 reduces neuronal maturation by targeting
a ubiquitin ligase, mindbomb homolog 1 (Mib1) (Smrt et al., 2010).
Single-nucleotide polymorphism (SNP) in miR-137 and its target
genes have been associated with schizophrenia (Ripke et al., 2011),
presumably due to dysregulation of neurodevelopment.
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brains (Cheng et al., 2007; Lukiw, 2007). Brain speciﬁc expression of
miR-219 was also observed in zebraﬁsh (Kapsimali et al., 2007). It has
been shown that miR-219 is both necessary and sufﬁcient to promote
oligodendrocyte differentiation in mouse and zebraﬁsh by repressing
negative regulators of oligodendrocyte differentiation (Dugas et al.,
2010; Zhao et al., 2010b). In a recent study, miR-219was shown to pro-
mote neural precursor cell differentiation in zebraﬁsh spinal cord by
inhibiting apical polarity proteins, par-3 family cell polarity regulator
(PARD) and protein kinase C, iota (PRKCI) (Hudish et al., 2013). More-
over, miR-219 regulates pain behavior in mouse spinal neurons by
targeting calcium/calmodulin-dependent protein kinase II γ subunit
(CaMKIIγ) and regulating N-methyl-D-aspartate (NMDA) receptor sig-
naling transduction (Pan et al., 2014). Since interference with NMDA-
mediated glutamate signaling has been linked to behavioral deﬁcits in
schizophrenia, an association between miR-219 and schizophrenia has
been suggested, which will be discussed in the next section.
miR-132 is an activity-dependent miRNA that plays an important
role in neuronal plasticity, synaptic physiology and memory. Overex-
pression of miR-132 in primary cortical, hippocampal and olfactory
bulb neurons promoted neurite outgrowth, enhanced dendritic length
and complexity, and stimulated activity-dependent spine formation,
whereas inhibition of miR-132 or deletion of themiR-132/212 locus in-
duced opposite effects (Edbauer et al., 2010; Impey et al., 2010; Magill
et al., 2010; Pathania et al., 2012; Vo et al., 2005; Wayman et al.,
2008). The effect of miR-132 on dendritic morphogenesis is mediated
in part by targeting p250GAP (Rho GTPase-activating protein 32),
which in turn activates RAC1 (a Rho family, small GTP binding
protein)-PAK (the p21-activated kinase)-mediated spinogenesis
(Impey et al., 2010; Wayman et al., 2008). miR-132 was also reported
to targetmethyl CpG-binding protein 2 (MeCP2), a regulator of dendritic
morphology and synapse formation (Klein et al., 2007). In addition to
neuronal morphology, miR-132 regulates newborn neuron integration
and synaptic transmission. Overexpression of miR-132 increased
paired-pulse ratio, a measure for changes in presynaptic release proba-
bility, anddecreased synaptic depression (Lambert et al., 2010),whereas
inhibition or knockout of miR-132 impaired the integration of newborn
neurons into the excitatory synaptic circuitry, reduced the frequency of
miniature excitatory post-synaptic currents (mEPSCs), and blunted
basal synaptic transmission (Impey et al., 2010; Luikart et al., 2011;
Remenyi et al., 2013). Recently it was shown that miR-132 expression
was modulated by visual experience, and miR-132 in turn regulated
visual cortex plasticity (Mellios et al., 2011; Tognini et al., 2011). A link
between miR-132 expression and cognition has also been established.
Transgenic overexpression of miR-132 in the forebrain impaired recog-
nition memory (Hansen et al., 2010; Scott et al., 2012). In contrast,
induced expression of endogenous miR-132 in response to a spatial
memory task enhanced cognition (Hansen et al., 2013), suggests that
the expression level of miR-132 is tightly regulated to control learning
and memory (Bicker et al., 2014). The expression of miR-132 is dysreg-
ulated in a number of neurodevelopmental disorders (Kim et al., 2010;
Klein et al., 2007; Packer et al., 2008). The knowledge on miR-132
expression and function in normal neurodevelopment may shed light
on the pathological origins of the neurodevelopmental diseases.
miRNAs in schizophrenia
Multiple studies suggest that defective neuronal plasticity and func-
tion in neurodevelopmental disordersmay have resulted from impaired
posttranscriptional regulation mediated by miRNAs (Hunsberger et al.,
2009). Increasing evidence suggests that miRNAs play important roles
in the etiology of neuropsychiatric, neurodevelopmental disorders,
and neurodegenerative diseases (Olde Loohuis et al., 2012).
Schizophrenia is a devastating neuropsychiatric disorder of neuro-
developmental origin, arising through complex interplay between ge-
netic and epigenetic factors (Harrison, 1997). Although schizophreniais considered largely heritable, with an estimated rate of heritability
about 80%, the effect of susceptibility genes has been small (Purcell
et al., 2009). Because miRNAs play essential roles in brain development
and have the ability to target multiple genes, the potential roles for
miRNAs in the abnormal brain development in schizophrenia have
been investigated (Kolshus et al., 2013). Interestingly, patients with
DiGeorge 22q11.2 deletion, which affects a key miRNA processing
gene DGCR8, showed a 30-fold increase in the risk of schizophrenia
(Stark et al., 2008). A hot spot for neurodevelopmental disorders,
including schizophrenia, has also been described on chromosome 8p,
in which at least seven miRNAs are located (Tabares-Seisdedos and
Rubenstein, 2009).
The largest Genome-Wide Association Study (GWAS) in schizophre-
nia withmore than 40,000 individuals, revealed that the strongest asso-
ciation of SNP with schizophrenia laywithin the intron of a putative
primary transcript for miR-137 (Ripke et al., 2011), a known regulator
of neurodevelopment (Silber et al., 2008; Smrt et al., 2010; Sun et al.,
2011). This associationwas conﬁrmed in other independent association
studies (Green et al., 2013; Potkin et al., 2009). Other schizophrenia
SNPs that achieved genome-wide signiﬁcance include several miR-137
target genes, including transcription factor 4 (TCF4), calcium channel,
voltage-dependent, L type, alpha 1C subunit (CACNA1C), CUB and
Sushi multiple domains 1 (CSMD1), chromosome 10 open reading
frame 26 (C10orf26), and zinc ﬁnger protein 804A (ZNF804A) (Kim
et al., 2012; Kwon et al., 2013; Ripke et al., 2011). Subsequent studies re-
vealed that variation in miR-137 speciﬁcally affected brain activation
and functional connectivity in individuals with genetic/familial risk of
schizophrenia, but not in control subjects (Mothersill et al., 2014;
Whalley et al., 2012). The essential role of miR-137 in neuro-
development and its association with schizophrenia reinforces the
concept that schizophrenia is a disorder of neurodevelopment.
Microdeletion of chromosome region containing the miR-137 gene
has also been linked to intellectual disability (Willemsen et al., 2011).
Moreover, SNP in other miRNAs, such as miR-206, miR-198, and
miR-30e, have also been associated with schizophrenia in different
ethnic groups (Feng et al., 2009; Hansen et al., 2007; Xu et al., 2010).
In addition to SNP in miRNAs, SNP in target genes of different
miRNAs have been identiﬁed. For example, the SNP rs10759 (A N C) in
the regulator of G protein signaling 4 (RGS4) gene, a downstream target
of miR-124, is predicted to increase the risk of schizophrenia (Gong
et al., 2013). Decreased expression of RGS4 has been observed in the
frontal cortex and superior temporal gyrus of schizophrenia patients
(Bowden et al., 2007; Erdely et al., 2006). The rs10759 SNP changes
the binding of miR-124 to RGS4. miR-124 inhibits the expression of
RGS4 by binding to the 3′ UTR of RGS4 with rs10759 (C), but does not
bind to the 3′ UTR of RGS4 with rs10759 (A) (Gong et al., 2013). The
dopamine receptor D2 (DRD2) gene, a downstream target of miR-9, is
also implicated in the pathophysiology of schizophrenia. The SNP
rs1801028 (Cys311Ser) in DRD2 is linked to schizophrenia in a meta-
analysis (Glatt et al., 2003; Shi et al., 2014). An inverse correlation in
the expression of DRD2 and miR-9 has been observed in regions of
human brains implicated in schizophrenia (Shi et al., 2014). The
pathological signiﬁcance of miR-9 and miR-124 and their relevant
target genes in schizophrenia is worthy of further investigation.
Several studies analyzed miRNA levels in postmortem brains from
schizophrenia patients and identiﬁed multiple miRNAs that are differ-
entially expressed (Beveridge et al., 2008, 2010; Burmistrova et al.,
2007; Kim et al., 2010; Mellios et al., 2009, 2012; Miller et al., 2012;
Moreau et al., 2011; Perkins et al., 2007; Santarelli et al., 2011; Wong
et al., 2013; Zhu et al., 2009). Some of these dysregulated miRNAs
could modulate the expression of genes associated with schizophrenia
(Kocerha et al., 2009; Miller et al., 2012). Initial studies on post-
mortem brains revealed an overall decrease in miRNA expression in
the prefrontal cortex of schizophrenia patients (Perkins et al., 2005,
2007). These miRNAs include miR-26b, miR-29b, miR-30b, and miR-
106b. A subsequent independent study showed that the expression of
50 E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53miR-132 and miR-132* was signiﬁcantly decreased in brains of
schizophrenia patients (Miller et al., 2012). miR-132 has been shown
to potentiate NMDA receptor depolarization (Cheng et al., 2007).
The reduced expression of miR-132 in schizophrenia patients is consis-
tent with the hypofunction of the NMDA receptor in schizophrenia
patients.
Later studies reported an increase in the expression of a set of
miRNAs in medial temporal regions of schizophrenia patients
(Beveridge et al., 2008, 2010; Santarelli et al., 2011), coinciding with el-
evated expression of components in the miRNA biogenesis machinery
(Beveridge et al., 2008, 2010; Santarelli et al., 2011). The upregulated
miRNAs include miR-219, miR-181b, and miR-15 family members
(Beveridge et al., 2008, 2010). Of interest, miR-219 functions tomediate
the behavioral effects of Dizocilpine, an antagonist of the N-methyl-D-
aspartate (NMDA) receptor (Kocerha et al., 2009). Acute treatment
with Dizocilpine decreased the levels of miR-219 in the prefrontal
cortex, whereas inhibition of miR-219 action suppressed Dizocilpine-
induced hyperlocomotion and stereotypies. Thus, elevated expression
of miR-219 in the dorsolateral prefrontal cortex from schizophrenia
patients (Beveridge et al., 2010; Smalheiser et al., 2014) is consistent
with the NMDA receptor hypoactivity theory of schizophrenia (Miller
and Wahlestedt, 2010). Manipulating the expression or activity of
miR-219 may therefore provide a potential therapeutic tool for the
treatment of schizophrenia.
miRNAs in bipolar disorder
Bipolar disorder is a severe neuropsychiatric disease characterized
by mood swings between mania and depression. Although they are
two disease entities, bipolar disorder and schizophrenia have many
overlapping symptoms. Moreover, these two disorders are frequently
concurrent in affected families and have similar epidemiological
risks (Lichtenstein et al., 2009; Purcell et al., 2009). Indeed, bipolar
disorder shares genetic risk factors with schizophrenia and, like schizo-
phrenia, has an estimated heritability rate of 70–80% (Kolshus et al.,
2013). As in schizophrenia, the problem of multiple susceptibility
genes of small effect has led to an increased interest in deﬁning the
roles of miRNAs in bipolar disorder because one miRNA can target
hundreds of genes.
Most miRNA studies in bipolar disorder used postmortem samples,
many of which included schizophrenia subjects (Kolshus et al., 2013).
Several of these studies identiﬁed overlapped change in miRNA levels
between bipolar disorder and schizophrenia (Kim et al., 2010; Moreau
et al., 2011), suggesting common molecular basis shared by these dis-
eases (Purcell et al., 2009). In a study on patients with bipolar disorder,
schizophrenia, and psychiatrically normal control subjects, all miRNAs
that have reduced expression in the schizophrenia patient group
(relative to control subjects) also exhibit reduced expression in
the bipolar disorder patient group. These miRNAs include miR-15a,
miR-22, miR-33, miR-106b, miR-138, miR-151, miR-210, miR-324-5p,
miR-338, miR-339 and miR-425 (Moreau et al., 2011). On the other
hand, some miRNAs such as miR-219, exhibited elevated expression in
the prefrontal cortex of both schizophrenia and bipolar disorder
patients relative to the control group (Smalheiser et al., 2014).
Patients with bipolar disorder are usually treated with mood
stabilizers, including lithium and valporate (Bowden et al., 1994; Pope
et al., 1991). It has been shown that several miRNAs, including let-7b,
let-7c, miR-128a, miR-24a, miR-30c, miR-34a, and miR-221, were up-
regulated after treatment with the mood stabilizers, lithium and
valporate (Zhou et al., 2009). In an effort to identify peripheral bio-
markers for bipolar disorder, miR-134 was identiﬁed as a blood marker
of clinical status in bipolar disorder patients (Rong et al., 2011). Both in
drug-free and medicated patients, a negative correlation was observed
between miR-134 levels and manic symptoms (Rong et al., 2011).
These studies suggest that miRNAs have the potential to serve as both
therapeutic targets and biomarkers for bipolar disorders.Perspectives
This review aims to emphasize the signiﬁcance of miRNAs in
neurodevelopment and summarize the potential link between dysregu-
lated miRNAs and the etiology of two related neurodevelopmental
disorders, schizophrenia and bipolar disorder. Deﬁning the role of
these miRNAs in normal neurodevelopment may help us to probe the
pathological mechanisms of related neurodevelopmental disorders.
Although we are still at the infant stage of genetic studies on miRNA-
related genes, the recent annotation of new miRNA SNPs paves the
road for growing research interest in this ﬁeld. Next generation
sequencing (NGS) technology will allow rapid development in this
area. New miRNAs will also be identiﬁed due to the development of
NGS, which will paint a more comprehensive picture of miRNA net-
works in brain development and disorders. Such picture will improve
our understanding on the molecular mechanisms underlying the
phenotypes of neurodevelopmental diseases, and ultimately lead to
the development of more effective therapies for these disorders by
targeting relevant miRNAs and their target genes.
Acknowledgments
This work was supported by California Institute for Regenerative
Medicine grant TR2-01832 and RB4-06277.
References
Akerblom, M., Sachdeva, R., Barde, I., Verp, S., Gentner, B., Trono, D., Jakobsson, J., 2012.
MicroRNA-124 is a subventricular zone neuronal fate determinant. J. Neurosci. 32,
8879–8889.
Ambasudhan, R., Talantova, M., Coleman, R., Yuan, X., Zhu, S., Lipton, S.A., Ding, S., 2011.
Direct reprogramming of adult human ﬁbroblasts to functional neurons under
deﬁned conditions. Cell Stem Cell 9, 113–118.
Ambros, V., 2004. The functions of animal microRNAs. Nature 431, 350–355.
Andersson, T., Rahman, S., Sansom, S.N., Alsio, J.M., Kaneda, M., Smith, J., O'Carroll, D.,
Tarakhovsky, A., Livesey, F.J., 2010. Reversible block of mouse neural stem cell
differentiation in the absence of dicer and microRNAs. PLoS One 5, e13453.
Annibali, D., Gioia, U., Savino, M., Laneve, P., Caffarelli, E., Nasi, S., 2012. A new module in
neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9
and -103, target the differentiation inhibitor ID2. PLoS One 7, e40269.
Arvanitis, D.N., Jungas, T., Behar, A., Davy, A., 2010. Ephrin-B1 reverse signaling controls a
posttranscriptional feedback mechanism via miR-124. Mol. Cell. Biol. 30, 2508–2517.
Bartel, D.P., 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116,
281–297.
Beveridge, N.J., Tooney, P.A., Carroll, A.P., Gardiner, E., Bowden, N., Scott, R.J., Tran, N.,
Dedova, I., Cairns, M.J., 2008. Dysregulation of miRNA 181b in the temporal cortex
in schizophrenia. Hum. Mol. Genet. 17, 1156–1168.
Beveridge, N.J., Gardiner, E., Carroll, A.P., Tooney, P.A., Cairns, M.J., 2010. Schizophrenia is
associated with an increase in cortical microRNA biogenesis. Mol. Psychiatry 15,
1176–1189.
Bian, S., Sun, T., 2011. Functions of noncoding RNAs in neural development and neurolog-
ical diseases. Mol. Neurobiol. 44, 359–373.
Bian, S., Hong, J., Li, Q., Schebelle, L., Pollock, A., Knauss, J.L., Garg, V., Sun, T., 2013.
MicroRNA cluster miR-17-92 regulates neural stem cell expansion and transition to
intermediate progenitors in the developingmouse neocortex. Cell Rep. 3, 1398–1406.
Bicker, S., Lackinger, M., Weiss, K., Schratt, G., 2014. MicroRNA-132, -134, and -138: a
microRNA troika rules in neuronal dendrites. Cell. Mol. Life Sci. http://dx.doi.org/10.
1007/s00018-014-1671-7.
Bonev, B., Pisco, A., Papalopulu, N., 2011. MicroRNA-9 reveals regional diversity of neural
progenitors along the anterior–posterior axis. Dev. Cell 20, 19–32.
Bonev, B., Stanley, P., Papalopulu, N., 2012. MicroRNA-9 modulates Hes1 ultradian oscilla-
tions by forming a double-negative feedback loop. Cell Rep. 2, 10–18.
Bowden, C.L., Brugger, A.M., Swann, A.C., Calabrese, J.R., Janicak, P.G., Petty, F., Dilsaver, S.C.
, Davis, J.M., Rush, A.J., Small, J.G., et al., 1994. Efﬁcacy of divalproex vs lithium and
placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271,
918–924.
Bowden, N.A., Scott, R.J., Tooney, P.A., 2007. Altered expression of regulator of G-protein
signalling 4 (RGS4) mRNA in the superior temporal gyrus in schizophrenia.
Schizophr. Res. 89, 165–168.
Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S.,
Wernig, M., Tajonar, A., Ray, M.K., Bell, G.W., Otte, A.P., Vidal, M., Gifford, D.K.,
Young, R.A., Jaenisch, R., 2006. Polycomb complexes repress developmental regula-
tors in murine embryonic stem cells. Nature 441, 349–353.
Burmistrova, O.A., Goltsov, A.Y., Abramova, L.I., Kaleda, V.G., Orlova, V.A., Rogaev, E.I.,
2007. MicroRNA in schizophrenia: genetic and expression analysis of miR-130b
(22q11). Biochemistry (Mosc.) 72, 578–582.
Cao, X., Pfaff, S.L., Gage, F.H., 2007. A functional study of miR-124 in the developing neural
tube. Genes Dev. 21, 531–536.
51E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53Chen, J.A., Huang, Y.P., Mazzoni, E.O., Tan, G.C., Zavadil, J., Wichterle, H., 2011. Mir-17-3p
controls spinal neural progenitor patterning by regulating Olig2/Irx3 cross-repressive
loop. Neuron 69, 721–735.
Cheng, H.Y., Papp, J.W., Varlamova, O., Dziema, H., Russell, B., Curfman, J.P., Nakazawa, T.,
Shimizu, K., Okamura, H., Impey, S., Obrietan, K., 2007. MicroRNA modulation of
circadian-clock period and entrainment. Neuron 54, 813–829.
Cheng, L.C., Pastrana, E., Tavazoie, M., Doetsch, F., 2009. miR-124 regulates adult
neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 12, 399–408.
Choi, P.S., Zakhary, L., Choi, W.Y., Caron, S., Alvarez-Saavedra, E., Miska, E.A., McManus, M.,
Harfe, B., Giraldez, A.J., Horvitz, H.R., Schier, A.F., Dulac, C., 2008. Members of the
miRNA-200 family regulate olfactory neurogenesis. Neuron 57, 41–55.
Clovis, Y.M., Enard, W., Marinaro, F., Huttner, W.B., De Pietri Tonelli, D., 2012. Convergent
repression of Foxp2 3′UTR by miR-9 and miR-132 in embryonic mouse neocortex:
implications for radial migration of neurons. Development 139, 3332–3342.
Coolen, M., Thieffry, D., Drivenes, O., Becker, T.S., Bally-Cuif, L., 2012. miR-9 controls the
timing of neurogenesis through the direct inhibition of antagonistic factors. Dev.
Cell 22, 1052–1064.
Cuellar, T.L., Davis, T.H., Nelson, P.T., Loeb, G.B., Harfe, B.D., Ullian, E., McManus, M.T., 2008.
Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes
in the absence of neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 105, 5614–5619.
Dajas-Bailador, F., Bonev, B., Garcez, P., Stanley, P., Guillemot, F., Papalopulu, N., 2012.
microRNA-9 regulates axon extension and branching by targeting Map1b in mouse
cortical neurons. Nat. Neurosci. 15, 697–699.
Davila, J.L., Goff, L.A., Ricupero, C.L., Camarillo, C., Oni, E.N., Swerdel, M.R., Toro-Ramos, A.J.,
Li, J., Hart, R.P., 2014. A positive feedback mechanism that regulates expression of
miR-9 during neurogenesis. PLoS One 9, e94348.
Davis, T.H., Cuellar, T.L., Koch, S.M., Barker, A.J., Harfe, B.D., McManus, M.T., Ullian, E.M.,
2008. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cor-
tex and hippocampus. J. Neurosci. 28, 4322–4330.
De Pietri Tonelli, D., Pulvers, J.N., Haffner, C., Murchison, E.P., Hannon, G.J., Huttner, W.B.,
2008. miRNAs are essential for survival and differentiation of newborn neurons but
not for expansion of neural progenitors during early neurogenesis in the mouse em-
bryonic neocortex. Development 135, 3911–3921.
Delaloy, C., Liu, L., Lee, J.A., Su, H., Shen, F., Yang, G.Y., Young, W.L., Ivey, K.N., Gao, F.B.,
2010. MicroRNA-9 coordinates proliferation and migration of human embryonic
stem cell-derived neural progenitors. Cell Stem Cell 6, 323–335.
Deo, M., Yu, J.Y., Chung, K.H., Tippens, M., Turner, D.L., 2006. Detection of mammalian
microRNA expression by in situ hybridization with RNA oligonucleotides. Dev. Dyn.
235, 2538–2548.
Du, Z.W., Ma, L.X., Phillips, C., Zhang, S.C., 2013. miR-200 and miR-96 families repress
neural induction from human embryonic stem cells. Development 140, 2611–2618.
Dugas, J.C., Cuellar, T.L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J.L., Foo, L.C.,
McManus, M.T., Barres, B.A., 2010. Dicer1 and miR-219 are required for normal
oligodendrocyte differentiation and myelination. Neuron 65, 597–611.
Edbauer, D., Neilson, J.R., Foster, K.A., Wang, C.F., Seeburg, D.P., Batterton, M.N., Tada, T.,
Dolan, B.M., Sharp, P.A., Sheng, M., 2010. Regulation of synaptic structure and func-
tion by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65, 373–384.
Erdely, H.A., Tamminga, C.A., Roberts, R.C., Vogel, M.W., 2006. Regional alterations in RGS4
protein in schizophrenia. Synapse 59, 472–479.
Feng, J., Sun, G., Yan, J., Noltner, K., Li, W., Buzin, C.H., Longmate, J., Heston, L.L., Rossi, J.,
Sommer, S.S., 2009. Evidence for X-chromosomal schizophrenia associated with
microRNA alterations. PLoS One 4, e6121.
Ferreira, M.A., O'Donovan, M.C., Meng, Y.A., Jones, I.R., Ruderfer, D.M., Jones, L., Fan, J.,
Kirov, G., Perlis, R.H., Green, E.K., Smoller, J.W., Grozeva, D., Stone, J., Nikolov, I.,
Chambert, K., Hamshere, M.L., Nimgaonkar, V.L., Moskvina, V., Thase, M.E., Caesar, S.,
Sachs, G.S., Franklin, J., Gordon-Smith, K., Ardlie, K.G., Gabriel, S.B., Fraser, C.,
Blumenstiel, B., Defelice, M., Breen, G., Gill, M., Morris, D.W., Elkin, A., Muir, W.J.,
McGhee, K.A., Williamson, R., MacIntyre, D.J., MacLean, A.W., St, C.D., Robinson, M.,
Van Beck, M., Pereira, A.C., Kandaswamy, R., McQuillin, A., Collier, D.A., Bass, N.J.,
Young, A.H., Lawrence, J., Ferrier, I.N., Anjorin, A., Farmer, A., Curtis, D., Scolnick, E.M.,
McGufﬁn, P., Daly, M.J., Corvin, A.P., Holmans, P.A., Blackwood, D.H., Gurling, H.M.,
Owen, M.J., Purcell, S.M., Sklar, P., Craddock, N., 2008. Collaborative genome-wide
association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat.
Genet. 40, 1056–1058.
Franke, K., Otto, W., Johannes, S., Baumgart, J., Nitsch, R., Schumacher, S., 2012. miR-124-
regulated RhoG reduces neuronal process complexity via ELMO/Dock180/Rac1 and
Cdc42 signalling. EMBO J. 31, 2908–2921.
Gao, F.B., 2010. Context-dependent functions of speciﬁc microRNAs in neuronal develop-
ment. Neural Dev. 5, 25.
Garg, N., Po, A., Miele, E., Campese, A.F., Begalli, F., Silvano, M., Infante, P., Capalbo, C., De
Smaele, E., Canettieri, G., Di Marcotullio, L., Screpanti, I., Ferretti, E., Gulino, A., 2013.
MicroRNA-17-92 cluster is a direct Nanog target and controls neural stem cell
through Trp53inp1. EMBO J. 32, 2819–2832.
Giraldez, A.J., Cinalli, R.M., Glasner, M.E., Enright, A.J., Thomson, J.M., Baskerville, S.,
Hammond, S.M., Bartel, D.P., Schier, A.F., 2005. MicroRNAs regulate brain morpho-
genesis in zebraﬁsh. Science 308, 833–838.
Glatt, S.J., Faraone, S.V., Tsuang, M.T., 2003. Meta-analysis identiﬁes an association be-
tween the dopamine D2 receptor gene and schizophrenia. Mol. Psychiatry 8,
911–915.
Gong, Y.,Wu, C.N., Xu, J., Feng, G., Xing, Q.H., Fu,W., Li, C., He, L., Zhao, X.Z., 2013. Polymor-
phisms in microRNA target sites inﬂuence susceptibility to schizophrenia by
altering the binding of miRNAs to their targets. Eur. Neuropsychopharmacol. 23,
1182–1189.
Goodfellow, M., Phillips, N.E., Manning, C., Galla, T., Papalopulu, N., 2014. MicroRNA input
into a neural ultradian oscillator controls emergence and timing of alternative cell
states. Nat. Commun. 5, 3399.Green, M.J., Cairns, M.J., Wu, J., Dragovic, M., Jablensky, A., Tooney, P.A., Scott, R.J., Carr, V.J.,
2013. Genome-wide supported variant MIR137 and severe negative symptoms
predict membership of an impaired cognitive subtype of schizophrenia. Mol. Psychiatry
18, 774–780.
Gu, X., Meng, S., Liu, S., Jia, C., Fang, Y., Li, S., Fu, C., Song, Q., Lin, L.,Wang, X., 2014.miR-124
represses ROCK1 expression to promote neurite elongation through activation of the
PI3K/Akt signal pathway. J. Mol. Neurosci. 52, 156–165.
Guan, F., Zhang, B., Yan, T., Li, L., Liu, F., Li, T., Feng, Z., Zhang, B., Liu, X., Li, S., 2014. MIR137
gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility
in Han Chinese. Schizophr. Res. 152, 97–104.
Hancock, M.L., Preitner, N., Quan, J., Flanagan, J.G., 2014. MicroRNA-132 is enriched in
developing axons, locally regulates Rasa1 mRNA, and promotes axon extension. J.
Neurosci. 34, 66–78.
Hansen, T., Olsen, L., Lindow, M., Jakobsen, K.D., Ullum, H., Jonsson, E., Andreassen, O.A.,
Djurovic, S., Melle, I., Agartz, I., Hall, H., Timm, S., Wang, A.G., Werge, T., 2007. Brain
expressed microRNAs implicated in schizophrenia etiology. PLoS One 2, e873.
Hansen, K.F., Sakamoto, K., Wayman, G.A., Impey, S., Obrietan, K., 2010. Transgenic
miR132 alters neuronal spine density and impairs novel object recognition memory.
PLoS One 5, e15497.
Hansen, K.F., Karelina, K., Sakamoto, K., Wayman, G.A., Impey, S., Obrietan, K., 2013.
miRNA-132: a dynamic regulator of cognitive capacity. Brain Struct. Funct. 218,
817–831.
Harrison, P.J., 1997. Schizophrenia: a disorder of neurodevelopment? Curr. Opin.
Neurobiol. 7, 285–289.
Hill, M.J., Donocik, J.G., Nuamah, R.A., Mein, C.A., Sainz-Fuertes, R., Bray, N.J., 2014.
Transcriptional consequences of schizophrenia candidate miR-137 manipulation in
human neural progenitor cells. Schizophr. Res. 153, 225–230.
Hudish, L.I., Blasky, A.J., Appel, B., 2013. miR-219 regulates neural precursor differentiation
by direct inhibition of apical par polarity proteins. Dev. Cell 27, 387–398.
Hunsberger, J.G., Austin, D.R., Chen, G., Manji, H.K., 2009. MicroRNAs in mental health:
from biological underpinnings to potential therapies. Neuromolecular Med. 11,
173–182.
Impey, S., Davare, M., Lasiek, A., Fortin, D., Ando, H., Varlamova, O., Obrietan, K., Soderling,
T.R., Goodman, R.H., Wayman, G.A., 2010. An activity-induced microRNA controls
dendritic spine formation by regulating Rac1-PAK signaling. Mol. Cell. Neurosci. 43,
146–156.
Kapsimali, M., Kloosterman, W.P., de Bruijn, E., Rosa, F., Plasterk, R.H., Wilson, S.W., 2007.
MicroRNAs show a wide diversity of expression proﬁles in the developing and
mature central nervous system. Genome Biol. 8, R173.
Kawase-Koga, Y., Low, R., Otaegi, G., Pollock, A., Deng, H., Eisenhaber, F., Maurer-Stroh, S.,
Sun, T., 2010. RNase-III enzyme Dicer maintains signaling pathways for differentia-
tion and survival in mouse cortical neural stem cells. J. Cell Sci. 123, 586–594.
Kim, V.N., 2005. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol.
Cell Biol. 6, 376–385.
Kim, J., Inoue, K., Ishii, J., Vanti, W.B., Voronov, S.V., Murchison, E., Hannon, G., Abeliovich,
A., 2007. A microRNA feedback circuit in midbrain dopamine neurons. Science 317,
1220–1224.
Kim, A.H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J.L., van den
Oord, E.J., Riley, B.P., Kendler, K.S., Vladimirov, V.I., 2010. MicroRNA expression proﬁl-
ing in the prefrontal cortex of individuals affectedwith schizophrenia and bipolar dis-
orders. Schizophr. Res. 124, 183–191.
Kim, A.H., Parker, E.K., Williamson, V., McMichael, G.O., Fanous, A.H., Vladimirov, V.I.,
2012. Experimental validation of candidate schizophrenia gene ZNF804A as target
for hsa-miR-137. Schizophr. Res. 141, 60–64.
Klein, M.E., Lioy, D.T., Ma, L., Impey, S., Mandel, G., Goodman, R.H., 2007. Homeostatic
regulation of MeCP2 expression by a CREB-induced microRNA. Nat. Neurosci. 10,
1513–1514.
Kocerha, J., Faghihi, M.A., Lopez-Toledano, M.A., Huang, J., Ramsey, A.J., Caron, M.G., Sales,
N., Willoughby, D., Elmen, J., Hansen, H.F., Orum, H., Kauppinen, S., Kenny, P.J.,
Wahlestedt, C., 2009. MicroRNA-219 modulates NMDA receptor-mediated neurobe-
havioral dysfunction. Proc. Natl. Acad. Sci. U. S. A. 106, 3507–3512.
Kolshus, E., Dalton, V.S., Ryan, K.M., McLoughlin, D.M., 2013. When less is more —
microRNAs and psychiatric disorders. Acta Psychiatr. Scand. 129, 241–256.
Kosik, K.S., 2006. The neuronal microRNA system. Nat. Rev. Neurosci. 7, 911–920.
Kosik, K.S., Krichevsky, A.M., 2005. The elegance of the microRNAs: a neuronal perspec-
tive. Neuron 47, 779–782.
Krichevsky, A.M., King, K.S., Donahue, C.P., Khrapko, K., Kosik, K.S., 2003. A microRNA
array reveals extensive regulation of microRNAs during brain development. RNA 9,
1274–1281.
Krichevsky, A.M., Sonntag, K.C., Isacson, O., Kosik, K.S., 2006. Speciﬁc microRNAsmodulate
embryonic stem cell-derived neurogenesis. Stem Cells 24, 857–864.
Kwon, E.,Wang,W., Tsai, L.H., 2013. Validation of schizophrenia-associated genes CSMD1,
C10orf26, CACNA1C and TCF4 as miR-137 targets. Mol. Psychiatry 18, 11–12.
Lagos-Quintana, M., Rauhut, R., Yalcin, A., Meyer, J., Lendeckel, W., Tuschl, T., 2002.
Identiﬁcation of tissue-speciﬁc microRNAs from mouse. Curr. Biol. 12, 735–739.
Lambert, T.J., Storm, D.R., Sullivan, J.M., 2010. MicroRNA132 modulates short-term
synaptic plasticity but not basal release probability in hippocampal neurons. PLoS
One 5, e15182.
Laneve, P., Gioia, U., Andriotto, A., Moretti, F., Bozzoni, I., Caffarelli, E., 2010. Aminicircuitry
involving REST and CREB controls miR-9-2 expression during human neuronal differ-
entiation. Nucleic Acids Res. 38, 6895–6905.
Lang, M.F., Shi, Y., 2012. Dynamic roles of microRNAs in neurogenesis. Front. Neurosci. 6,
71.
Leucht, C., Stigloher, C., Wizenmann, A., Klafke, R., Folchert, A., Bally-Cuif, L., 2008.
MicroRNA-9 directs late organizer activity of the midbrain–hindbrain boundary.
Nat. Neurosci. 11, 641–648.
52 E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53Li, X., Jin, P., 2010. Roles of small regulatory RNAs in determining neuronal identity. Nat.
Rev. Neurosci. 11, 329–338.
Li, Y., Wang, F., Lee, J.A., Gao, F.B., 2006. MicroRNA-9a ensures the precise speciﬁcation of
sensory organ precursors in Drosophila. Genes Dev. 20, 2793–2805.
Lichtenstein, P., Yip, B.H., Bjork, C., Pawitan, Y., Cannon, T.D., Sullivan, P.F., Hultman, C.M.,
2009. Common genetic determinants of schizophrenia and bipolar disorder in
Swedish families: a population-based study. Lancet 373, 234–239.
Lim, L.P., Lau, N.C., Garrett-Engele, P., Grimson, A., Schelter, J.M., Castle, J., Bartel, D.P.,
Linsley, P.S., Johnson, J.M., 2005. Microarray analysis shows that some microRNAs
downregulate large numbers of target mRNAs. Nature 433, 769–773.
Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.J., Hammond, S.M.,
Joshua-Tor, L., Hannon, G.J., 2004. Argonaute2 is the catalytic engine of mammalian
RNAi. Science 305, 1437–1441.
Liu, H.K., Belz, T., Bock, D., Takacs, A., Wu, H., Lichter, P., Chai, M., Schutz, G., 2008. The
nuclear receptor tailless is required for neurogenesis in the adult subventricular
zone. Genes Dev. 22, 2473–2478.
Liu, K., Liu, Y., Mo, W., Qiu, R., Wang, X., Wu, J.Y., He, R., 2011. MiR-124 regulates early
neurogenesis in the optic vesicle and forebrain, targeting NeuroD1. Nucleic Acids
Res. 39, 2869–2879.
Liu, C., Teng, Z.Q., McQuate, A.L., Jobe, E.M., Christ, C.C., von Hoyningen-Huene, S.J., Reyes,
M.D., Polich, E.D., Xing, Y., Li, Y., Guo, W., Zhao, X., 2013. An epigenetic feedback
regulatory loop involving microRNA-195 and MBD1 governs neural stem cell
differentiation. PLoS One 8, e51436.
Luikart, B.W., Bensen, A.L., Washburn, E.K., Perederiy, J.V., Su, K.G., Li, Y., Kernie, S.G.,
Parada, L.F., Westbrook, G.L., 2011. miR-132 mediates the integration of newborn
neurons into the adult dentate gyrus. PLoS One 6, e19077.
Lukiw,W.J., 2007.Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocam-
pus. Neuroreport 18, 297–300.
Luxenhofer, G., Helmbrecht, M.S., Langhoff, J., Giusti, S.A., Refojo, D., Huber, A.B., 2014.
MicroRNA-9 promotes the switch from early-born to late-born motor neuron popu-
lations by regulating Onecut transcription factor expression. Dev. Biol. 386, 358–370.
Magill, S.T., Cambronne, X.A., Luikart, B.W., Lioy, D.T., Leighton, B.H., Westbrook, G.L.,
Mandel, G., Goodman, R.H., 2010. MicroRNA-132 regulates dendritic growth
and arborization of newborn neurons in the adult hippocampus. Proc. Natl. Acad.
Sci. U. S. A. 107, 20382–20387.
Maiorano, N.A., Mallamaci, A., 2009. Promotion of embryonic cortico-cerebral
neuronogenesis by miR-124. Neural Dev. 4, 40.
Makeyev, E.V., Zhang, J., Carrasco, M.A., Maniatis, T., 2007. The microRNA miR-124 pro-
motes neuronal differentiation by triggering brain-speciﬁc alternative pre-mRNA
splicing. Mol. Cell 27, 435–448.
Mao, S., Li, H., Sun, Q., Zen, K., Zhang, C.Y., Li, L., 2014. miR-17 regulates the proliferation
and differentiation of the neural precursor cells during mouse corticogenesis. FEBS J.
281, 1144–1158.
Mellios, N., Huang, H.S., Baker, S.P., Galdzicka, M., Ginns, E., Akbarian, S., 2009. Molecular
determinants of dysregulated GABAergic gene expression in the prefrontal cortex of
subjects with schizophrenia. Biol. Psychiatry 65, 1006–1014.
Mellios, N., Sugihara, H., Castro, J., Banerjee, A., Le, C., Kumar, A., Crawford, B., Strathmann,
J., Tropea, D., Levine, S.S., Edbauer, D., Sur, M., 2011. miR-132, an experience-
dependent microRNA, is essential for visual cortex plasticity. Nat. Neurosci. 14,
1240–1242.
Mellios, N., Galdzicka, M., Ginns, E., Baker, S.P., Rogaev, E., Xu, J., Akbarian, S., 2012.
Gender-speciﬁc reduction of estrogen-sensitive small RNA, miR-30b, in subjects
with schizophrenia. Schizophr. Bull. 38, 433–443.
Miller, B.H., Wahlestedt, C., 2010. MicroRNA dysregulation in psychiatric disease. Brain
Res. 1338, 89–99.
Miller, B.H., Zeier, Z., Xi, L., Lanz, T.A., Deng, S., Strathmann, J., Willoughby, D., Kenny, P.J.,
Elsworth, J.D., Lawrence, M.S., Roth, R.H., Edbauer, D., Kleiman, R.J., Wahlestedt, C.,
2012. MicroRNA-132 dysregulation in schizophrenia has implications for both
neurodevelopment and adult brain function. Proc. Natl. Acad. Sci. U. S. A. 109,
3125–3130.
Morante, J., Vallejo, D.M., Desplan, C., Dominguez, M., 2013. Conserved miR-8/miR-200
deﬁnes a glial niche that controls neuroepithelial expansion and neuroblast transi-
tion. Dev. Cell 27, 174–187.
Moreau, M.P., Bruse, S.E., David-Rus, R., Buyske, S., Brzustowicz, L.M., 2011. Altered
microRNA expression proﬁles in postmortem brain samples from individuals with
schizophrenia and bipolar disorder. Biol. Psychiatry 69, 188–193.
Mothersill, O., Morris, D.W., Kelly, S., Rose, E.J., Fahey, C., O'Brien, C., Lyne, R., Reilly, R., Gill,
M., Corvin, A.P., Donohoe, G., 2014. Effects of MIR137 on fronto-amygdala functional
connectivity. Neuroimage 90, 189–195.
Naka-Kaneda, H., Nakamura, S., Igarashi, M., Aoi, H., Kanki, H., Tsuyama, J., Tsutsumi, S.,
Aburatani, H., Shimazaki, T., Okano, H., 2014. The miR-17/106-p38 axis is a key regu-
lator of the neurogenic-to-gliogenic transition in developing neural stem/progenitor
cells. Proc. Natl. Acad. Sci. U. S. A. 111, 1604–1609.
Neo, W.H., Yap, K., Lee, S.H., Looi, L.S., Khandelia, P., Neo, S.X., Makeyev, E.V., Su, I.H., 2014.
MicroRNA miR-124 controls the choice between neuronal and astrocyte differentia-
tion by ﬁne-tuning Ezh2 expression. J. Biol. Chem. 289, 20788–20801.
Obernier, K., Simeonova, I., Fila, T., Mandl, C., Holzl-Wenig, G., Monaghan-Nichols, P.,
Ciccolini, F., 2011. Expression of Tlx in both stem cells and transit amplifying progen-
itors regulates stem cell activation and differentiation in the neonatal lateral
subependymal zone. Stem Cells 29, 1415–1426.
Olde Loohuis, N.F., Kos, A., Martens, G.J., Van Bokhoven, H., Nadif Kasri, N., Aschraﬁ, A.,
2012. MicroRNA networks direct neuronal development and plasticity. Cell. Mol.
Life Sci. 69, 89–102.
Otaegi, G., Pollock, A., Hong, J., Sun, T., 2011. MicroRNA miR-9 modiﬁes motor neuron
columns by a tuning regulation of FoxP1 levels in developing spinal cords. J. Neurosci.
31, 809–818.Packer, A.N., Xing, Y., Harper, S.Q., Jones, L., Davidson, B.L., 2008. The bifunctional
microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in
Huntington's disease. J. Neurosci. 28, 14341–14346.
Pan, Z., Zhu, L.J., Li, Y.Q., Hao, L.Y., Yin, C., Yang, J.X., Guo, Y., Zhang, S., Hua, L., Xue, Z.Y., Zhang,
H., Cao, J.L., 2014. Epigeneticmodiﬁcation of spinalmiR-219 expression regulates chronic
Inﬂammation pain by targeting CaMKIIgamma. J. Neurosci. 34, 9476–9483.
Pathania, M., Torres-Reveron, J., Yan, L., Kimura, T., Lin, T.V., Gordon, V., Teng, Z.Q., Zhao, X.,
Fulga, T.A., Van Vactor, D., Bordey, A., 2012. miR-132 enhances dendritic morphogene-
sis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons.
PLoS One 7, e38174.
Peng, C., Li, N., Ng, Y.K., Zhang, J., Meier, F., Theis, F.J., Merkenschlager, M., Chen,W.,Wurst,
W., Prakash, N., 2012. A unilateral negative feedback loop between miR-200
microRNAs and Sox2/E2F3 controls neural progenitor cell-cycle exit and differentia-
tion. J. Neurosci. 32, 13292–13308.
Perkins, D.O., Jeffries, C., Sullivan, P., 2005. Expanding the ‘central dogma’: the regulatory
role of nonprotein coding genes and implications for the genetic liability to
schizophrenia. Mol. Psychiatry 10, 69–78.
Perkins, D.O., Jeffries, C.D., Jarskog, L.F., Thomson, J.M., Woods, K., Newman, M.A., Parker, J.
S., Jin, J., Hammond, S.M., 2007. MicroRNA expression in the prefrontal cortex of
individuals with schizophrenia and schizoaffective disorder. Genome Biol. 8, R27.
Pope Jr., H.G., McElroy, S.L., Keck Jr., P.E., Hudson, J.I., 1991. Valproate in the treatment of
acute mania. A placebo-controlled study. Arch. Gen. Psychiatry 48, 62–68.
Potkin, S.G., Turner, J.A., Fallon, J.A., Lakatos, A., Keator, D.B., Guffanti, G., Macciardi, F.,
2009. Gene discovery through imaging genetics: identiﬁcation of two novel genes
associated with schizophrenia. Mol. Psychiatry 14, 416–428.
Purcell, S.M., Wray, N.R., Stone, J.L., Visscher, P.M., O'Donovan, M.C., Sullivan, P.F., Sklar, P.,
2009. Common polygenic variation contributes to risk of schizophrenia and bipolar
disorder. Nature 460, 748–752.
Qu, Q., Sun, G., Li, W., Yang, S., Ye, P., Zhao, C., Yu, R.T., Gage, F.H., Evans, R.M., Shi, Y., Qu, Q.,
Sun, G., Li, W., Yang, S., Ye, P., Zhao, C., Yu, R.T., Gage, F.H., Evans, R.M., Shi, Y., 2010.
Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate
neural stem cell proliferation and self-renewal. Nat. Cell Biol. 12, 31–39 (sup).
Qurashi, A., Jin, P., 2010. Small RNA-mediated gene regulation in neurodevelopmental
disorders. Curr. Psychiatry Rep. 12, 154–161.
Rajasethupathy, P., Fiumara, F., Sheridan, R., Betel, D., Puthanveettil, S.V., Russo, J.J., Sander, C.,
Tuschl, T., Kandel, E., 2009. Characterization of small RNAs in Aplysia reveals a role for
miR-124 in constraining synaptic plasticity through CREB. Neuron 63, 803–817.
Remenyi, J., van den Bosch, M.W., Palygin, O., Mistry, R.B., McKenzie, C., Macdonald, A.,
Hutvagner, G., Arthur, J.S., Frenguelli, B.G., Pankratov, Y., 2013.miR-132/212 knockout
mice reveal roles for these miRNAs in regulating cortical synaptic transmission and
plasticity. PLoS One 8, e62509.
Ripke, S., Sanders, A.R., Kendler, K.S., Levinson, D.F., Sklar, P., Holmans, P.A., Lin, D.-Y., et al.,
2011. Genome-wide association study identiﬁes ﬁve new schizophrenia loci. Nat.
Genet. 43, 969–976.
Rong, H., Liu, T.B., Yang, K.J., Yang, H.C.,Wu, D.H., Liao, C.P., Hong, F., Yang, H.Z.,Wan, F., Ye,
X.Y., Xu, D., Zhang, X., Chao, C.A., Shen, Q.J., 2011. MicroRNA-134 plasma levels before
and after treatment for bipolar mania. J. Psychiatr. Res. 45, 92–95.
Santarelli, D.M., Beveridge, N.J., Tooney, P.A., Cairns, M.J., 2011. Upregulation of dicer and
microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in
schizophrenia. Biol. Psychiatry 69, 180–187.
Sanuki, R., Onishi, A., Koike, C., Muramatsu, R., Watanabe, S., Muranishi, Y., Irie, S., Uneo, S.,
Koyasu, T., Matsui, R., Cherasse, Y., Urade, Y., Watanabe, D., Kondo, M., Yamashita, T.,
Furukawa, T., 2011. miR-124a is required for hippocampal axogenesis and retinal
cone survival through Lhx2 suppression. Nat. Neurosci. 14, 1125–1134.
Saunders, L.R., Sharma, A.D., Tawney, J., Nakagawa, M., Okita, K., Yamanaka, S.,
Willenbring, H., Verdin, E., 2010. miRNAs regulate SIRT1 expression during mouse
embryonic stem cell differentiation and in adult mouse tissues. Aging (Albany NY)
2, 415–431.
Scott, H.L., Tamagnini, F., Narduzzo, K.E., Howarth, J.L., Lee, Y.B., Wong, L.F., Brown, M.W.,
Warburton, E.C., Bashir, Z.I., Uney, J.B., 2012. MicroRNA-132 regulates recognition
memory and synaptic plasticity in the perirhinal cortex. Eur. J. Neurosci. 36,
2941–2948.
Sempere, L.F., Freemantle, S., Pitha-Rowe, I., Moss, E., Dmitrovsky, E., Ambros, V., 2004.
Expression proﬁling of mammalian microRNAs uncovers a subset of brain-
expressed microRNAs with possible roles in murine and human neuronal differenti-
ation. Genome Biol. 5, R13.
Shi, Y., Lie, C.D., Taupin, P., Nakashima, K., Ray, J., Yu, R.T., Gage, F.H., Evans, R.M., 2004.
Expression and function of orphan nuclear receptor TLX in adult neural stem cells.
Nature 427, 78–83.
Shi, Y., Sun, G., Zhao, C., Stewart, R., 2008. Neural stem cell self-renewal. Crit. Rev. Oncol.
Hematol. 65, 43–53.
Shi, Y., Zhao, X., Hsieh, J., Wichterle, H., Impey, S., Banerjee, S., Neveu, P., Kosik, K.S., 2010.
MicroRNA regulation of neural stem cells and neurogenesis. J. Neurosci. 30,
14931–14936.
Shi, W., Du, J., Qi, Y., Liang, G., Wang, T., Li, S., Xie, S., Zeshan, B., Xiao, Z., 2012. Aberrant
expression of serum miRNAs in schizophrenia. J. Psychiatr. Res. 46, 198–204.
Shi, S., Leites, C., He, D., Schwartz, D., Moy, W., Shi, J., Duan, J., 2014. MicroRNA-9 and
microRNA-326 regulate human dopamine D2 receptor expression, and the
microRNA-mediated expression regulation is altered by a genetic variant. J. Biol.
Chem. 289, 13434–13444.
Shibata, M., Kurokawa, D., Nakao, H., Ohmura, T., Aizawa, S., 2008. MicroRNA-9modulates
Cajal–Retzius cell differentiation by suppressing Foxg1 expression in mouse medial
pallium. J. Neurosci. 28, 10415–10421.
Shibata, M., Nakao, H., Kiyonari, H., Abe, T., Aizawa, S., 2011. MicroRNA-9 regulates
neurogenesis in mouse telencephalon by targeting multiple transcription factors. J.
Neurosci. 31, 3407–3422.
53E. Sun, Y. Shi / Experimental Neurology 268 (2015) 46–53Silber, J., Lim, D.A., Petritsch, C., Persson, A.I., Maunakea, A.K., Yu, M., Vandenberg, S.R.,
Ginzinger, D.G., James, C.D., Costello, J.F., Bergers, G., Weiss, W.A., Alvarez-Buylla, A.,
Hodgson, J.G., 2008. miR-124 and miR-137 inhibit proliferation of glioblastoma
multiforme cells and induce differentiation of brain tumor stem cells. BMCMed. 6, 14.
Sklar, P., Smoller, J.W., Fan, J., Ferreira, M.A., Perlis, R.H., Chambert, K., Nimgaonkar, V.L.,
McQueen, M.B., Faraone, S.V., Kirby, A., de Bakker, P.I., Ogdie, M.N., Thase, M.E.,
Sachs, G.S., Todd-Brown, K., Gabriel, S.B., Sougnez, C., Gates, C., Blumenstiel, B.,
Defelice, M., Ardlie, K.G., Franklin, J., Muir, W.J., McGhee, K.A., MacIntyre, D.J.,
McLean, A., VanBeck, M., McQuillin, A., Bass, N.J., Robinson, M., Lawrence, J., Anjorin,
A., Curtis, D., Scolnick, E.M., Daly, M.J., Blackwood, D.H., Gurling, H.M., Purcell, S.M.,
2008. Whole-genome association study of bipolar disorder. Mol. Psychiatry 13,
558–569.
Smalheiser, N.R., Lugli, G., Zhang, H., Rizavi, H., Cook, E.H., Dwivedi, Y., 2014. Expression of
microRNAs and other small RNAs in prefrontal cortex in schizophrenia, bipolar
disorder and depressed subjects. PLoS One 9, e86469.
Smirnova, L., Grafe, A., Seiler, A., Schumacher, S., Nitsch, R., Wulczyn, F.G., 2005. Regulation of
miRNA expression during neural cell speciﬁcation. Eur. J. Neurosci. 21, 1469–1477.
Smrt, R.D., Szulwach, K.E., Pfeiffer, R.L., Li, X., Guo, W., Pathania, M., Teng, Z.Q., Luo, Y.,
Peng, J., Bordey, A., Jin, P., Zhao, X., 2010. MicroRNA miR-137 regulates neuronal
maturation by targeting ubiquitin ligase mind bomb-1. Stem Cells 28, 1060–1070.
Stark, K.L., Xu, B., Bagchi, A., Lai, W.S., Liu, H., Hsu, R., Wan, X., Pavlidis, P., Mills, A.A.,
Karayiorgou, M., Gogos, J.A., 2008. Altered brain microRNA biogenesis contributes
to phenotypic deﬁcits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760.
Stefani, G., Slack, F.J., 2008. Small non-coding RNAs in animal development. Nat. Rev. Mol.
Cell Biol. 9, 219–230.
Sun, G., Ye, P., Murai, K., Lang, M.F., Li, S., Zhang, H., Li, W., Fu, C., Yin, J., Wang, A., Ma, X.,
Shi, Y., 2011. miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in
neural stem cells. Nat. Commun. 2, 529.
Szulwach, K.E., Li, X., Smrt, R.D., Li, Y., Luo, Y., Lin, L., Santistevan, N.J., Li, W., Zhao, X., Jin, P.,
2010. Cross talk between microRNA and epigenetic regulation in adult neurogenesis.
J. Cell Biol. 189, 127–141.
Tabares-Seisdedos, R., Rubenstein, J.L., 2009. Chromosome 8p as a potential hub for
developmental neuropsychiatric disorders: implications for schizophrenia, autism
and cancer. Mol. Psychiatry 14, 563–589.
Tan, S.L., Ohtsuka, T., Gonzalez, A., Kageyama, R., 2012. MicroRNA9 regulates neural stem
cell differentiation by controlling Hes1 expression dynamics in the developing brain.
Genes Cells 17, 952–961.
Tognini, P., Putignano, E., Coatti, A., Pizzorusso, T., 2011. Experience-dependent expres-
sion of miR-132 regulates ocular dominance plasticity. Nat. Neurosci. 14, 1237–1239.
Visvanathan, J., Lee, S., Lee, B., Lee, J.W., Lee, S.K., 2007. The microRNA miR-124 antago-
nizes the anti-neural REST/SCP1 pathway during embryonic CNS development.
Genes Dev. 21, 744–749.
Vo, N., Klein, M.E., Varlamova, O., Keller, D.M., Yamamoto, T., Goodman, R.H., Impey, S.,
2005. A cAMP-response element binding protein-induced microRNA regulates neu-
ronal morphogenesis. Proc. Natl. Acad. Sci. U. S. A. 102, 16426–16431.
Volvert, M.L., Prevot, P.P., Close, P., Laguesse, S., Pirotte, S., Hemphill, J., Rogister, F., Kruzy,
N., Sacheli, R., Moonen, G., Deiters, A., Merkenschlager, M., Chariot, A., Malgrange, B.,
Godin, J.D., Nguyen, L., 2014. MicroRNA targeting of CoREST controls polarization of
migrating cortical neurons. Cell Rep. 7, 1168–1183.
Wang, X.,Wang, Z.H.,Wu, Y.Y., Tang,H., Tan, L.,Wang, X., Gao, X.Y., Xiong, Y.S., Liu, D.,Wang, J.
Z., Zhu, L.Q., 2013. Melatonin attenuates scopolamine-induced memory/synaptic disor-
der by rescuing EPACs/miR-124/Egr1 pathway. Mol. Neurobiol. 47, 373–381.Wayman, G.A., Davare, M., Ando, H., Fortin, D., Varlamova, O., Cheng, H.Y., Marks, D.,
Obrietan, K., Soderling, T.R., Goodman, R.H., Impey, S., 2008. An activity-regulated
microRNA controls dendritic plasticity by down-regulating p250GAP. Proc. Natl.
Acad. Sci. U. S. A. 105, 9093–9098.
Whalley, H.C., Papmeyer, M., Romaniuk, L., Sprooten, E., Johnstone, E.C., Hall, J., Lawrie, S.
M., Evans, K.L., Blumberg, H.P., Sussmann, J.E., McIntosh, A.M., 2012. Impact of a
microRNA MIR137 susceptibility variant on brain function in people at high genetic
risk of schizophrenia or bipolar disorder. Neuropsychopharmacology 37, 2720–2729.
Willemsen, M.H., Valles, A., Kirkels, L.A., Mastebroek, M., Olde Loohuis, N., Kos, A.,
Wissink-Lindhout, W.M., de Brouwer, A.P., Nillesen, W.M., Pfundt, R., Holder-Espinasse,
M., Vallee, L., Andrieux, J., Coppens-Hofman, M.C., Rensen, H., Hamel, B.C., van
Bokhoven, H., Aschraﬁ, A., Kleefstra, T., 2011. Chromosome 1p21.3 microdeletions com-
prising DPYD and MIR137 are associated with intellectual disability. J. Med. Genet. 48,
810–818.
Wong, J., Duncan, C.E., Beveridge, N.J., Webster, M.J., Cairns, M.J., Weickert, C.S., 2013.
Expression of NPAS3 in the human cortex and evidence of its posttranscriptional
regulation by miR-17 during development, with implications for schizophrenia.
Schizophr. Bull. 39, 396–406.
Xu, Y., Li, F., Zhang, B., Zhang, K., Zhang, F., Huang, X., Sun, N., Ren, Y., Sui, M., Liu, P., 2010.
MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated
with schizophrenia. Schizophr. Res. 119, 219–227.
Yang, Y., Shu, X., Liu, D., Shang, Y.,Wu, Y., Pei, L., Xu, X., Tian, Q., Zhang, J., Qian, K., Wang, Y.
X., Petralia, R.S., Tu, W., Zhu, L.Q., Wang, J.Z., Lu, Y., 2012. EPAC null mutation impairs
learning and social interactions via aberrant regulation of miR-124 and Zif268
translation. Neuron 73, 774–788.
Yang, L., Chao, J., Kook, Y.H., Gao, Y., Yao, H., Buch, S.J., 2013. Involvement of miR-9/
MCPIP1 axis in PDGF-BB-mediated neurogenesis in neuronal progenitor cells. Cell
Death Dis 4, e960.
Yoo, A.S., Staahl, B.T., Chen, L., Crabtree, G.R., 2009. MicroRNA-mediated switching of
chromatin-remodelling complexes in neural development. Nature 460, 642–646.
Yoo, A.S., Sun, A.X., Li, L., Shcheglovitov, A., Portmann, T., Li, Y., Lee-Messer, C., Dolmetsch,
R.E., Tsien, R.W., Crabtree, G.R., 2011. MicroRNA-mediated conversion of human
ﬁbroblasts to neurons. Nature 476, 228–231.
Zhang, C.L., Zou, Y., He, W., Gage, F.H., Evans, R.M., 2008. A role for adult TLX-positive
neural stem cells in learning and behaviour. Nature 451, 1004–1007.
Zhao, C., Sun, G., Li, S., Shi, Y., 2009. A feedback regulatory loop involving microRNA-9 and
nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 16,
365–371.
Zhao, C., Sun, G., Li, S., Lang, M., Yang, S., Li, W., Shi, Y., 2010a. MicroRNA let-7b regulates
neural stem cell proliferation and differentiation by targeting nuclear receptor TLX
signaling. Proc. Natl. Acad. Sci. U. S. A. 107, 1876–1881.
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.S., Xin, M., Wang, F.,
Appel, B., Lu, Q.R., 2010b.MicroRNA-mediated control of oligodendrocyte differentiation.
Neuron 65, 612–626.
Zhao, C., Sun, G., Ye, P., Li, S., Shi, Y., 2013. MicroRNA let-7d regulates the TLX/microRNA-9
cascade to control neural cell fate and neurogenesis. Sci. Rep. 3, 1329.
Zhou, R., Yuan, P., Wang, Y., Hunsberger, J.G., Elkahloun, A., Wei, Y., Damschroder-
Williams, P., Du, J., Chen, G., Manji, H.K., 2009. Evidence for selective microRNAs
and their effectors as common long-term targets for the actions of mood stabilizers.
Neuropsychopharmacology 34, 1395–1405.
Zhu, Y., Kalbﬂeisch, T., Brennan, M.D., Li, Y., 2009. A microRNA gene is hosted in an intron
of a schizophrenia-susceptibility gene. Schizophr. Res. 109, 86–89.
